Dr. Yuan Yuan, MD is an Associate Professor of Medical Oncology and Therapeutics Research at the City of Hope National Medical Center. Dr. Yuan completed her Masters in Oncology at Peking Union Medical College in Beijing, China and her Ph.D. in Biochemistry and Molecular Biology at the University of California, Riverside. She completed her residency in Internal Medicine at New York University Downtown Hospital and her fellowship in Hematology/Oncology from New York University Medical Center under the direction of Dr. Franco Muggia, a giant in Medical Oncology. Dr. Yuan’s clinical and research ..read more

Dr. James Allison, PhD is Regental Professor and Chair of the Department of Immunology, the Olga Keith Wiess Distinguished University Chair for Cancer Research, Director of the Parker Institute for Cancer Research, and the Executive Director of the Immunotherapy Platform at MD Anderson Cancer Center. He has spent a distinguished career studying the regulation of T cell responses and developing strategies for cancer immunotherapy. He earned the 2018 Nobel Prize in Physiology or Medicine, which he shared with Dr. Tasuku Honjo, “for their discovery of cancer therapy by inhibition of negative immu ..read more

Steven Rosen, MD, is the Provost and Chief Scientific Officer for the City of Hope. He is also the Director of the Comprehensive Cancer Center and the Beckman Research Institute and holds the Irell & Manella Cancer Center Director's Distinguished Chair and the Morgan & Helen Chu Director’s Chair of the Beckman Research Institute. Following his graduation with distinction from Northwestern University’s Medical School’s six-year honors program in Chicago, Illinois, Dr. Rosen completed his residency in Internal Medicine at Northwestern and his fellowship in Hematology and Medica ..read more

Swaminathan Iyer, MD, is currently the Professor of the Department of Lymphoma/Myeloma at The University of Texas MD Anderson Cancer Center and Professor of Medicine at the Houston Methodist Academic Institute  and Weill Cornell Medicine. He completed his medical school from Bangalore Medical College, India and residency in Internal Medicine from Wayne State University, Michigan. He pursued a fellowship in Hematology/Oncology from Jackson Memorial Hospital, University of Miami, Florida. He is a nationally recognized leader in early drug development in hematologic malignancies. As the Sect ..read more

Today’s guest is Dr. Rowan Chlebowski, one of the most influential breast cancer researchers in the world. Dr. Chlebowski is a clinical breast oncologist with a Ph.D. in reproductive biology, he has a credentialed clinical and research interest in breast cancer therapy and prevention, menopausal hormone therapy influences on cancer and chronic disease, and lifestyle influences on breast cancer incidence and outcome. He is best known for studying breast cancer issues in the Women’s Health Initiative (WHI). He has published widely and led reports in well-cited journals such as JAMA,&nb ..read more

The guest of this episode is Heather Wakelee, M.D., a leading specialist in the treatment of lung cancer, thymoma and mesothelioma. Dr. Wakelee has been in practice for nearly two decades at Stanford University, and is currently a fellow of ASCO. She is the physician lead for the thoracic malignancies clinical research group and has developed research programs related to lung cancer and thymoma across multiple areas including clinical trials, translational work, and population sciences. Dr. Wakelee is the Principal Investigator on numerous clinical trials, and is the faculty director of the St ..read more

Dr. Nekhlyudov is an Associate Professor of Medicine at Harvard Medical School, the Clinical Director of Internal Medicine at David B. Perini Jr. Quality of Life Clinic, and an Internist at Longwood, and Brigham and Women’s Hospital. Dr. Nekhlyudov is renowned for her extensive clinical and research expertise in cancer survivorship, and overall is a stalwart source of wisdom in medicine.  We are grateful to have Dr. Nekhlyudov share her motivating messages on persistence, self-knowledge, and skillful discernment in receiving guidance from mentors and other colleagues. Though this segment ..read more

Today we have the honor of sharing our interview with Dr. Clifford Hudis, the Chief Executive Officer of the American Society of Clinical Oncology. Dr. Hudis is indeed remarkably intelligent and strategically wise in his leadership roles, but he is also kind, generous, and relatable. It was a pleasure to hear Dr. Hudis’ wisdom on articulating a clear and focused vision, allowing passion to emerge and guide you, and always keeping the patient at the center of the work.  Thank you for joining us, and please do enjoy this gift of knowledge from Dr. Hudis. Talking points:  The power of ..read more

Dr. Marijo Bilusic combines clinical expertise with heart-based wisdom learned through his impressive career. Dr. Bilusic directs the NIH Hematology Oncology Fellowship which provides fellows with a strong clinical grounding in hematology and oncology as well as a comprehensive introduction to clinical, laboratory, and translational research. His current research interests focus on tumor immunology and development of treatment options for prostate cancer and other genitourinary tumors using novel targeted agents, therapeutic cancer vaccines, antibodies, or immune modulators.  On this epis ..read more

For this episode we had the pleasure and privilege of learning from Dr. Anthony Back, one of the leading pioneers in the field of clinical communication. Dr. Back is a physician at Colorectal Services at UW Medical Center, co-director of the UW Center for Excellence in Palliative Care and a UW Professor of Oncology and Medicine as well as an Adjunct Professor of Bioethics and Humanities. Dr. Back was the principal investigator for the Oncotalk interventions, he co-wrote Mastering Communications with Seriously Ill Patients, and he co-founded the mobile app VitalTalk for improving clinician comm ..read more